Abstract
A recent study (Sulkowski et al., 2020) reveals that oncometabolites, which are produced by metabolic gene mutations in many cancers, sensitize cells to PARP inhibition by antagonizing histone demethylation and obscuring epigenetic marks that are necessary for efficient DNA repair.
Original language | English (US) |
---|---|
Pages (from-to) | 368-370 |
Number of pages | 3 |
Journal | Molecular cell |
Volume | 79 |
Issue number | 3 |
DOIs | |
State | Published - Aug 6 2020 |
ASJC Scopus subject areas
- Molecular Biology
- Cell Biology